Quarterly report pursuant to Section 13 or 15(d)

RESTRUCTURING CHARGES (Tables)

v3.22.2.2
RESTRUCTURING CHARGES (Tables)
9 Months Ended
Sep. 30, 2022
RESTRUCTURING CHARGES.  
Schedule of employee severance, benefits and related costs

During the nine months ended September 30, 2022, the Company recorded the following activity in accrued expenses and other current liabilities on the balance sheet (in thousands):

Nine Months Ended

September 30, 2022

Accrued expenses, January 1, 2022

$

Restructuring charges

12,782

Cash payments

(1,478)

Stock-based compensation

(7,313)

Inventory write-off

(3,085)

Accrued expenses, September 30, 2022

$

906

Schedule of restructuring and related costs

During the three and nine months ended September 30, 2022, the Company recorded restructuring charges of $12.8 million related to employee severance, benefits and related costs, which were expensed as follows (in thousands):

Three Months Ended

Nine Months Ended

September 30, 2022

September 30, 2022

Cost of goods sold

$

3,085

$

3,126

Research and development(1)

8,117

Sales and marketing

667

General and administrative

 

489

Interest and other (expense) income, net

383

Total restructuring charges(2)

$

3,085

12,782

(1) Includes $7.3 million of stock-based compensation expense incurred in connection with the Initiative.

(2) Lease termination costs associated with the Initiative have yet to be determined, pending completion of the facility rationalization assessment. Other costs related to operational savings measures associated with the Initiative have yet to be determined.